Looking at where the problems come from, Donzé suggests that many of the core data issues faced by businesses today stem from ...
Let's look at the pros and cons of going full AI to help you understand how the value and purpose of software development ...
Steve Taplin is the CEO and cofounder of Sonatafy Technology, providing experienced nearshore software developers and ...
Enterprise AI adoption surged in 2025, but scaling still lags. Explore 7 key enterprise AI adoption trends shaping 2026—from ...
There is no doubt what took centre stage in the theatre of business applications in 25: agentic AI, surpassing pre-2022 AI, ...
Government agencies use SBOMs to expose hidden risks, govern artificial intelligence tools and speed response to software ...
When I look back at my 45 years of military service, one of the highlights of my military education was a battlefield tour I ...
Opinion
6dOpinion
AI Integration In MedTech Devices And Diagnostics: Regulation And Investment Opportunities
GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...
Discover iOS 26.2’s groundbreaking features like third-party payments, default apps, and customizable buttons. A new era for ...
Opinion
Fast Lane Only on MSNOpinion
Audi hands control of Italdesign to a US AI firm in surprise deal
Audi has quietly redrawn the map of European car design by handing control of Italdesign Giugiaro to a California based artificial intelligence specialist, turning a storied Turin studio into the ...
Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback